Merki H S, Witzel L, Walt R P, Neumann J, Scheurle E, Mappes A, Krammisch H, Heim J, Kaufmann D, Roehmel J
DRK Hospital Mark Brandenburg, Department of Gastroenterology Berlin, FRG.
Gut. 1988 Jan;29(1):81-4. doi: 10.1136/gut.29.1.81.
Continuous measurement of 24 hour intragastric acidity was carried out in 30 normal volunteers during treatment with placebo, cimetidine 800 mg, ranitidine 300 mg, and famotidine 40 mg in a double blind study. Medication was taken after the evening meal (post cenam nocte, PCN). Median 24 hour acidity decreased with all H2-receptor antagonists from 25.1 mmol/l on placebo to 10 mmol/l (-60.1%) during cimetidine, to 3.2 mmol/l (-87.25%) during ranitidine and to 2.5 mmol/l (-90.0%) during famotidine treatment (p less than 0.0005). All drugs significantly inhibited night time acidity but only famotidine decreased acidity during the late morning compared with placebo. Significantly greater acid reduction was seen with famotidine and ranitidine compared with cimetidine but no difference was found between famotidine and ranitidine.
在一项双盲研究中,对30名正常志愿者在服用安慰剂、800毫克西咪替丁、300毫克雷尼替丁和40毫克法莫替丁治疗期间进行了24小时胃内酸度的连续测量。药物在晚餐后服用(餐后夜间,PCN)。所有H2受体拮抗剂治疗后,24小时酸度中位数均下降,从安慰剂组的25.1毫摩尔/升降至西咪替丁治疗期间的10毫摩尔/升(-60.1%),雷尼替丁治疗期间降至3.2毫摩尔/升(-87.25%),法莫替丁治疗期间降至2.5毫摩尔/升(-90.0%)(p<0.0005)。所有药物均显著抑制夜间酸度,但与安慰剂相比,只有法莫替丁在上午晚些时候降低了酸度。与西咪替丁相比,法莫替丁和雷尼替丁的抑酸作用明显更强,但法莫替丁和雷尼替丁之间未发现差异。